Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing chemotherapy-induced-neutropenia in early-stage breast cancer patients

BACKGROUND: To compare the clinical value of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and pegylated rhG-CSF(PEG-rhG-CSF) in early-stage breast cancer (EBC) patients receiving adjuvant chemotherapy, compare the efficacy of PEG-rhG-CSF with different dose and explore the timin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yantao, Zhang, Ju, Zhong, Jianxin, Liao, Hao, Zhang, Jiayang, Liu, Yaxin, Liang, Yuehua, Li, Huiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373237/
https://www.ncbi.nlm.nih.gov/pubmed/37495949
http://dx.doi.org/10.1186/s12885-023-11198-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373237/
https://www.ncbi.nlm.nih.gov/pubmed/37495949
http://dx.doi.org/10.1186/s12885-023-11198-2

Ejemplares similares